3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
7
Sexual Dysfunctions, Psychological
1
Salivary Gland Neoplasms
1
Prostate Cancer Metastatic Disease
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Breast Diseases
1
Anatomic Stage III Breast Cancer AJCC v8
1
Advanced Breast Cancer
1
Interventions
Letrozole
4
Fulvestrant
4
trastuzumab deruxtecan
2
toripalimab
2
elacestrant
2
Injections
2
Anastrozole
2
AZD9833
2
ribociclib
1
palbociclib
1
exemestane
1
disitamab vedotin
1
abemaciclib
1
Selective Estrogen Receptor Modulators
1
Ritonavir
1
RAD1901
1
Paclitaxel
1
Lead
1
Itraconazole
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Everolimus
1
Alpelisib
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Breast Cancer
×
Gonadotropin-Releasing Hormone
×
90 days
×
Clear all
NCT06382948
2026-04-03
ADELA
MedSIR
Phase 3
Recruiting
240 enrolled